Showing 311-320 of 20328 results for "".
Fostering a "Back to Basics" Model in Type 2 Diabetes Care
https://reachmd.com/programs/diabetes-discourse/fostering-a-back-to-basics-model-for-type-2-diabetes-care/7584/For clinicians managing patients with T2DM, the clinical landscape for standards of care, diagnostic methods and techniques, and treatment options has become increasingly complex. Yet despite this challenge in keeping up to date with the latest recommendations, updated practice guidelines have alsoIs Reversing Retinopathy in Sight?
https://reachmd.com/programs/diabetes-discourse/is-reversing-retinopathy-in-sight/13634/Can this novel technology help us combat diabetes?Cerebral Edema in Children With Diabetes
https://reachmd.com/programs/focus-on-diabetes/cerebral-edema-in-children-with-diabetes/3860/Cerebral edema is the most common cause of death among children with diabetes, occurring as a complication of diabetic ketoacidosis (DKA) in about one percent of children with Type 1 diabetes. Among our young patients, who carries the greatest risk for cerebral edema? How can we prevent, recognize aNew-Onset Ketosis-Prone Diabetes in an Adult with Spinal Muscular Atrophy Type III
https://reachmd.com/programs/neurofrontiers/new-onset-ketosis-prone-diabetes-in-an-adult-with-spinal-muscular-atrophy-type-iii/36615/Diabetes Educators EmpowerED: Strategies for Optimizing Patient Outcomes With Emerging Weekly Insulin Therapies
https://reachmd.com/programs/cme/diabetes-educators-empowered-strategies-for-optimizing-patient-outcomes-with-emerging-weekly-insulin-therapies/48828/Learn how to optimize guideline-concordant care for patients with type 2 diabetes with this on-demand webcast—featuring the latest data on weekly insulin therapies and expert-informed strategies to support the future integration of these emerging agents in your practice.Adjustment to Diabetes Diagnosis / New Technology
https://reachmd.com/programs/clinicians-roundtable/adjustment-to-diabetes-diagnosis-new-technology/328/Dr. Laffel, chief of the Pediatric and Adolescent Section at Joslin Clinic and an Investigator in the section on Genetics and Epidemiology at Joslin Diabetes Center as well as an Associate Professor of Pediatrics at Harvard Medical School discusses adjustment to the diagnosis of Type 1 diabetes. ShThe International Diabetes Federation's Global Campaign
https://reachmd.com/programs/diabetes-discourse/the-international-diabetes-federations-global-campaign/4942/World Diabetes Day marks the annual global awareness campaign for diabetes by the International Diabetes Federation. The campaign’s theme of "diabetes education and prevention" is scheduled for five years. How will the IDF implement this broad campaign for both the health care professionals and peopOral Agents for Diabetes: What to Choose and When
https://reachmd.com/programs/diabetes-discourse/oral-agents-for-diabetes-what-to-choose-and-when/5340/We now have many choices of oral agents in the treatment of type 2 diabetes patients. But choosing the type and where they fit in the treatment algorithm can be a challenge. Join host Dr. Steven Edelman and his guest, director of the Harold Schnitzer Diabetes Health Center, Dr. Andrew Ahmann, as theThe Certified Diabetes Educator: A Key Role in the Diabetes Team
https://reachmd.com/programs/diabetes-discourse/the-certified-diabetes-educator-a-key-role-in-the-diabetes-team/5640/Diabetes educators focus on helping patients living with diabetes and related conditions achieve behavior change goals and lead to better clinical outcomes and improved health status. How has the role of the certified diabetes educator changed in the management of diabetes? Join host Dr. Steven EdelType1 Diabetes Cure Research & Autoimmune Diseases
https://reachmd.com/programs/clinicians-roundtable/type1-diabetes-cure-research-autoimmune-diseases/1772/Dr. Denise L. Faustman, Associate Professor of Medicine at Harvard Medical School and Director of the Immunobiology Laboratories at the Massachusetts General Hospital discusses how her Type 1 diabetes cure research may be applicable to other autoimmune diseases such as lupus.